CoChat

The Most Promising Next-Generation Probiotic Candidates—Impact on Human Health and Potential Application in Food Technology

Open access
Lalowski, Piotr, Zielińska, Dorota · 2024 · Fermentation
Cited by 30

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

A substantial body of research indicates that the gut microbiota exerts a profound influence on host health. The purpose of this work was to characterize selected, most promising, well-known next-generation probiotics (NGPs) and review the potential applications of the bacteria in food technology. The isolation of gut bacteria with significant health benefits has led to the emergence of NGPs. In contrast to traditional probiotics, these originate directly from the gut microbiota, thereby ensuring their optimal adaptation to the intestinal ecosystem. NGPs exert their effects on the host organism through a variety of mechanisms, including the synthesis of bioactive compounds, modulation of the gut microbiota, and metabolism of substances provided by the host. Several bacterial species have been identified as potential candidates for NGPs, including Akkermansia muciniphila, Faecalibacterium prausnitzii, Bacteroides thetaiotaomicron, Christensenella minuta, and many others. These bacteria have demonstrated the capacity to exert beneficial effects, including the reduction of obesity, type 2 diabetes, metabolic disorders, and even cancers. The greatest limitation to their commercialization is their lack of oxygen tolerance, which presents challenges not only for research but also for their potential application in food. The most optimal approach for their application in food appears to be microencapsulation. Further research is required to establish the safety of NGP supplementation and to protect them from environmental conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/fermentation10090444

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 93

  1. Zwierczyk, U., Sowada, C., and Duplaga, M. (2022). Eating Choices—The Roles of Motivation and Health Literacy: A Cross-Sectional Study. Nutrients, 14. · DOI
  2. Baz, 2023, The Impact of a Healthy Lifestyle on Psychological Well-Being Among Saudi Adolescent Girls Attending Secondary Schools in Taif City, Saudi Arabia, Cureus, 15, e50189
  3. Granato, 2020, Functional Foods: Product Develop-ment, Technological Trends, Efficacy Testing, and Safety, Annu. Rev. Food Sci. Technol., 11, 93, 10.1146/annurev-food-032519-051708 · DOI · Paper page
  4. Küçükgöz, K., and Trząskowska, M. (2022). Nondairy Probiotic Products: Functional Foods That Require More Attention. Nutrients, 14. · DOI
  5. Goetzke, 2014, Consumption of Organic and Functional Food. A Matter of Well-Being and Health?, Appetite, 77, 96, 10.1016/j.appet.2014.02.012 · DOI · Paper page
  6. Granato, 2010, Probiotic Dairy Products as Functional Foods, Compr. Rev. Food Sci. Food Saf., 9, 455, 10.1111/j.1541-4337.2010.00120.x · DOI · Paper page
  7. Ghelardi, E., Mazzantini, D., Celandroni, F., Calvigioni, M., Panattoni, A., Lupetti, A., Bois De Fer, B., and Perez, M. (2023). Analysis of the Microbial Content of Probiotic Products Commercialized Worldwide and Survivability in Conditions Mimicking the Human Gut Environment. Front. Microbiol., 14. · DOI
  8. Aponte, M., Murru, N., and Shoukat, M. (2020). Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective. Front. Microbiol., 11. · DOI
  9. Leeuwendaal, N.K., Stanton, C., O’Toole, P.W., and Beresford, T.P. (2022). Fermented Foods, Health and the Gut Microbiome. Nutrients, 14. · DOI · Paper page
  10. Negrete-Romero, B., Valencia-Olivares, C., Baños-Dossetti, G.A., Pérez-Armendáriz, B., and Cardoso-Ugarte, G.A. (2021). Nutritional Contributions and Health Associations of Traditional Fermented Foods. Fermentation, 7. · DOI
  11. Kruk, M., Lalowski, P., Hoffmann, M., Trząskowska, M., and Jaworska, D. (2024). Probiotic Bacteria Survival and Shelf Life of High Fibre Plant Snack—Model Study. Plant Foods Hum. Nutr. · DOI
  12. Patel, P., Butani, K., Kumar, A., Singh, S., and Prajapati, B.G. (2023). Effects of Fermented Food Consumption on Non-Communicable Diseases. Foods, 12. · DOI
  13. Salminen, 2021, The International Scientific Association of Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Postbiotics, Nat. Rev. Gastroenterol. Hepatol., 18, 649, 10.1038/s41575-021-00440-6 · DOI · Paper page
  14. Vera-Santander, V.E., Hernández-Figueroa, R.H., Jiménez-Munguía, M.T., Mani-López, E., and López-Malo, A. (2023). Health Benefits of Consuming Foods with Bacterial Probiotics, Postbiotics, and Their Metabolites: A Review. Molecules, 28. · DOI
  15. Aggarwal, S., Sabharwal, V., Kaushik, P., Joshi, A., Aayushi, A., and Suri, M. (2022). Postbiotics: From Emerging Concept to Application. Front. Sustain. Food Syst., 6. · DOI · Paper page
  16. Latif, A., Shehzad, A., Niazi, S., Zahid, A., Ashraf, W., Iqbal, M.W., Rehman, A., Riaz, T., Aadil, R.M., and Khan, I.M. (2023). Probiotics: Mechanism of Action, Health Benefits and Their Application in Food Industries. Front. Microbiol., 14. · DOI · Paper page
  17. Das, 2022, Current Status of Probiotic and Related Health Benefits, Appl. Food Res., 2, 100185, 10.1016/j.afres.2022.100185 · DOI · Paper page
  18. Borkent, 2022, Role of the Gut Microbiome in Three Major Psychiatric Disorders, Psychol. Med., 52, 1222, 10.1017/S0033291722000897 · DOI
  19. Al-Fakhrany, O.M., and Elekhnawy, E. (2024). Next-Generation Probiotics: The Upcoming Biotherapeutics. Mol. Biol. Rep., 51. · DOI · Paper page
  20. Hasnain, 2024, Research Trends of next Generation Probiotics, Food Sci. Biotechnol., 33, 2111, 10.1007/s10068-024-01626-9 · DOI
  21. Abouelela, M.E., and Helmy, Y.A. (2024). Next-Generation Probiotics as Novel Therapeutics for Improving Human Health: Current Trends and Future Perspectives. Microorganisms, 12. · DOI · Paper page
  22. Turnbaugh, 2007, The human microbiome project, Nature, 449, 804, 10.1038/nature06244 · DOI · Paper page
  23. Sender, R., Fuchs, S., and Milo, R. (2016). Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol., 14. · DOI
  24. Ooi, 2022, Intestinal Dysbiosis and Inflammation in Cystic Fibrosis Impacts Gut and Multi-Organ Axes, Med. Microecol., 13, 100057, 10.1016/j.medmic.2022.100057 · DOI
  25. Vernocchi, P., Del Chierico, F., and Putignani, L. (2020). Gut Microbiota Metabolism and Interaction with Food Components. Int. J. Mol. Sci., 21. · DOI · Paper page
  26. Conlon, 2015, The Impact of Diet and Lifestyle on Gut Microbiota and Human Health, Nutrients, 7, 17, 10.3390/nu7010017 · DOI · Paper page
  27. Rinninella, E., Cintoni, M., Raoul, P., Lopetuso, L.R., Scaldaferri, F., Pulcini, G., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. Nutrients, 11. · DOI · Paper page
  28. Ijssennagger, 2016, Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Dis-ease?, Trends Mol. Med., 22, 190, 10.1016/j.molmed.2016.01.002 · DOI · Paper page
  29. Kaliannan, K., Wang, B., Li, X.-Y., Kim, K.-J., and Kang, J.X. (2015). A Host-Microbiome Interaction Mediates the Opposing Effects of Omega-6 and Omega-3 Fatty Acids on Metabolic Endotoxemia. Sci. Rep., 5. · DOI · Paper page
  30. Sun, 2020, Chapter Eight—Diet, Nutrients and the Microbiome, Progress in Molecular Biology and Translational Science, Volume 171, 237, 10.1016/bs.pmbts.2020.04.006 · DOI · Paper page
  31. Reid, 2016, Probiotics: Definition, Scope and Mechanisms of Action, Best Pract. Res. Clin. Gastroenterol., 30, 17, 10.1016/j.bpg.2015.12.001 · DOI · Paper page
  32. Ng, Q.X., Lim, Y.L., Yaow, C.Y.L., Ng, W.K., Thumboo, J., and Liew, T.M. (2023). Effect of Probiotic Supplementation on Gut Microbiota in Patients with Major Depressive Disorders: A Systematic Review. Nutrients, 15. · DOI
  33. Klingbeil, 2018, Microbiota Modulation by Eating Patterns and Diet Composition: Impact on Food In-take, Am. J. Physiol. Regul. Integr. Comp. Physiol., 315, R1254, 10.1152/ajpregu.00037.2018 · DOI · Paper page
  34. Dimidi, 2020, Probiotics and Constipation: Mechanisms of Action, Evidence for Effectiveness and Utilisation by Patients and Healthcare Professionals, Proc. Nutr. Soc., 79, 147, 10.1017/S0029665119000934 · DOI · Paper page
  35. Chang, 2019, Next Generation Probiotics in Disease Amelioration, J. Food Drug Anal., 27, 615, 10.1016/j.jfda.2018.12.011 · DOI · Paper page
  36. Kubasova, T., Seidlerova, Z., and Rychlik, I. (2021). Ecological Adaptations of Gut Microbiota Members and Their Consequences for Use as a New Generation of Probiotics. Int. J. Mol. Sci., 22. · DOI
  37. Stavropoulou, E., and Bezirtzoglou, E. (2020). Probiotics in Medicine: A Long Debate. Front. Immunol., 11. · DOI · Paper page
  38. Derrien, 2008, The Mucin Degrader Akkermansia Muciniphila Is an Abundant Resident of the Human Intestinal Tract, Appl. Environ. Microbiol., 74, 1646, 10.1128/AEM.01226-07 · DOI · Paper page
  39. Hagi, 2021, The Interaction of Akkermansia Muciniphila with Host-Derived Substances, Bacteria and Diets, Appl. Microbiol. Biotechnol., 105, 4833, 10.1007/s00253-021-11362-3 · DOI · Paper page
  40. Aalvink, 2018, Model-Driven Design of a Minimal Medium for Akkermansia Muciniphila Confirms Mucus Adaptation, Microb. Biotechnol., 11, 476, 10.1111/1751-7915.13033 · DOI · Paper page
  41. Abuqwider, J.N., Mauriello, G., and Altamimi, M. (2021). Akkermansia Muciniphila, a New Generation of Beneficial Microbiota in Modulating Obesity: A Systematic Review. Microorganisms, 9. · DOI
  42. Miranda, 2024, A Next-Generation Bacteria (Akkermansia Muciniphila BAA-835) Presents Probiotic Potential Against Ovalbumin-Induced Food Allergy in Mice, Probiotics Antimicro. Prot., 16, 737, 10.1007/s12602-023-10076-4 · DOI
  43. Parrish, 2023, Akkermansia Muciniphila Exacerbates Food Allergy in Fibre-Deprived Mice, Nat. Microbiol., 8, 1863, 10.1038/s41564-023-01464-1 · DOI
  44. Cani, P.D., and de Vos, W.M. (2017). Next-Generation Beneficial Microbes: The Case of Akkermansia Muciniphila. Front. Microbiol., 8. · DOI · Paper page
  45. Machado, D., Barbosa, J.C., Domingos, M., Almeida, D., Andrade, J.C., Freitas, A.C., and Gomes, A.M. (2022). Revealing Antimi-crobial Resistance Profile of the Novel Probiotic Candidate Faecalibacterium Prausnitzii DSM 17677. Int. J. Food Microbiol., 363. · DOI
  46. He, X., Zhao, S., and Li, Y. (2021). Faecalibacterium Prausnitzii: A Next-Generation Probiotic in Gut Disease Improvement. Can. J. Infect. Dis. Med. Microbiol. · DOI · Paper page
  47. Maioli, T.U., Borras-Nogues, E., Torres, L., Barbosa, S.C., Martins, V.D., Langella, P., Azevedo, V.A., and Chatel, J.-M. (2021). Possible Benefits of Faecalibacterium Prausnitzii for Obesity-Associated Gut Disorders. Front. Pharmacol., 12. · DOI · Paper page
  48. Martín, R., Miquel, S., Benevides, L., Bridonneau, C., Robert, V., Hudault, S., Chain, F., Berteau, O., Azevedo, V., and Chatel, J.M. (2017). Functional Characterization of Novel Faecalibacterium Prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. Prausnitzii as a Next-Generation Probiotic. Front. Microbiol., 8. · DOI · Paper page
  49. Andrade, 2017, Action and Function of Faecalibacterium Prausnitzii in Health and Disease, Best Pract. Res. Clin. Gastroenterol., 31, 643, 10.1016/j.bpg.2017.09.011 · DOI · Paper page
  50. Khan, M.T., van Dijl, J.M., and Harmsen, H.J.M. (2014). Antioxidants Keep the Potentially Probiotic but Highly Oxygen-Sensitive Human Gut Bacterium Faecalibacterium Prausnitzii Alive at Ambient Air. PLoS ONE, 9. · DOI · Paper page
  51. Ryan, 2020, A High-Resolution Transcriptome Map Identifies Small RNA Regulation of Metabolism in the Gut Microbe Bacteroides Thetaiotaomicron, Nat. Commun., 11, 3557, 10.1038/s41467-020-17348-5 · DOI
  52. Ye, 2021, Polysaccharides Catabolism by the Human Gut Bacterium -Bacteroides Thetaiotaomicron: Advances and Perspectives, Crit. Rev. Food Sci. Nutr., 61, 3569, 10.1080/10408398.2020.1803198 · DOI
  53. Xu, 2004, Message from a Human Gut Symbiont: Sensitivity Is a Prerequisite for Sharing, Trends Microbiol., 12, 21, 10.1016/j.tim.2003.11.007 · DOI
  54. Comstock, 2003, Bacteroides Thetaiotaomicron: A Dynamic, Niche-Adapted Human Symbiont, BioEssays, 25, 926, 10.1002/bies.10350 · DOI · Paper page
  55. Wrzosek, L., Miquel, S., Noordine, M.-L., Bouet, S., Chevalier-Curt, M.J., Robert, V., Philippe, C., Bridonneau, C., Cherbuy, C., and Robbe-Masselot, C. (2013). Bacteroides Thetaiotaomicron and Faecalibacterium Prausnitziiinfluence the Production of Mucus Glycans and the Development of Goblet Cells in the Colonic Epithelium of a Gnotobiotic Model Rodent. BMC Biol., 11. · DOI · Paper page
  56. Wang, 2021, Roles of Intestinal Bacteroides in Human Health and Diseases, Crit. Rev. Food Sci. Nutr., 61, 3518, 10.1080/10408398.2020.1802695 · DOI · Paper page
  57. Durant, L., Stentz, R., Noble, A., Brooks, J., Gicheva, N., Reddi, D., O’Connor, M.J., Hoyles, L., McCartney, A.L., and Man, R. (2020). Bacteroides Thetaiotaomicron-Derived Outer Membrane Vesicles Promote Regulatory Dendritic Cell Responses in Health but Not in Inflammatory Bowel Disease. Microbiome, 8. · DOI
  58. Fonseca, S., Carvalho, A.L., Miquel-Clopés, A., Jones, E.J., Juodeikis, R., Stentz, R., and Carding, S.R. (2022). Extracellular Vesicles Produced by the Human Gut Commensal Bacterium Bacteroides Thetaiotaomicron Elicit Anti-Inflammatory Responses from Innate Immune Cells. Front. Microbiol., 13. · DOI
  59. Li, X., Kang, Y., Huang, Y., Xiao, Y., Song, L., Lu, S., and Ren, Z. (2021). A Strain of Bacteroides Thetaiotaomicron Attenuates Colonization of Clostridioides Difficile and Affects Intestinal Microbiota and Bile Acids Profile in a Mouse Model. Biomed. Pharmacother., 137. · DOI
  60. Elahi, M., Nakayama-Imaohji, H., Hashimoto, M., Tada, A., Yamasaki, H., Nagao, T., and Kuwahara, T. (2021). The Human Gut Microbe Bacteroides Thetaiotaomicron Suppresses Toxin Release from Clostridium Difficile by Inhibiting Autolysis. Antibiotics, 10. · DOI
  61. Hekelaar, 2019, Structural and Functional Char-acterization of a Family GH53 β-1,4-Galactanase from Bacteroides Thetaiotaomicron That Facilitates Degradation of Prebiotic Galactooligosaccharides, J. Struct. Biol., 205, 1, 10.1016/j.jsb.2018.12.002 · DOI
  62. Lammerts van Bueren, A., Mulder, M., van Leeuwen, S., and Dijkhuizen, L. (2017). Prebiotic Galactooligosaccharides Activate Mucin and Pectic Galactan Utilization Pathways in the Human Gut Symbiont Bacteroides Thetaiotaomicron. Sci. Rep., 7. · DOI
  63. 2021, A Comprehensive Review on the Impact of β-Glucan Metabolism by Bacteroides and Bifidobacterium Species as Members of the Gut Microbiota, Int. J. Biol. Macromol., 181, 877, 10.1016/j.ijbiomac.2021.04.069 · DOI
  64. Li, 2021, Discrete Genetic Loci in Human Gut Bacteroides Thetaiotaomicron Confer Pectin Metabolism, Carbohydr. Polym., 272, 118534, 10.1016/j.carbpol.2021.118534 · DOI
  65. Hu, 2021, Small Proline-Rich Protein 2A Is a Gut Bactericidal Protein Deployed during Helminth Infection, Science, 374, eabe6723, 10.1126/science.abe6723 · DOI
  66. Modasia, A., Parker, A., Jones, E., Stentz, R., Brion, A., Goldson, A., Defernez, M., Wileman, T., Ashley Blackshaw, L., and Carding, S.R. (2020). Regulation of Enteroendocrine Cell Networks by the Major Human Gut Symbiont Bacteroides Thetaiotaomicron. Front. Microbiol., 11. · DOI · Paper page
  67. Hansen, 2021, A Double-Blind, Placebo-Controlled Trial to Assess Safety and Tolerability of (Thetanix) Bacteroides Thetaiotaomicron in Adolescent Crohn’s Disease, Clin. Transl. Gastroenterol., 12, e00287, 10.14309/ctg.0000000000000287 · DOI
  68. Lai, Y., Hayashi, N., and Lu, T.K. (2022). Engineering the Human Gut Commensal Bacteroides Thetaiotaomicron with Synthetic Biology. Curr. Opin. Chem. Biol., 70. · DOI
  69. Curtis, 2014, The Gut Commensal Bacteroides Thetaiotaomicron Exacerbates Enteric Infection through Modification of the Metabolic Landscape, Cell Host Microbe, 16, 759, 10.1016/j.chom.2014.11.005 · DOI · Paper page
  70. Oba, S., Sunagawa, T., Tanihiro, R., Awashima, K., Sugiyama, H., Odani, T., Nakamura, Y., Kondo, A., Sasaki, D., and Sasaki, K. (2020). Prebiotic Effects of Yeast Mannan, Which Selectively Promotes Bacteroides Thetaiotaomicron and Bacteroides Ovatus in a Human Colonic Microbiota Model. Sci. Rep., 10. · DOI
  71. Ignatyeva, O., Tolyneva, D., Kovalyov, A., Matkava, L., Terekhov, M., Kashtanova, D., Zagainova, A., Ivanov, M., Yudin, V., and Makarov, V. (2024). Christensenella Minuta, a New Candidate next-Generation Probiotic: Current Evidence and Future Trajectories. Front. Microbiol., 14. · DOI
  72. Ang, W.-S., Law, J.W.-F., Letchumanan, V., Hong, K.W., Wong, S.H., Ab Mutalib, N.S., Chan, K.-G., Lee, L.-H., and Tan, L.T.-H. (2023). A Keystone Gut Bacterium Christensenella Minuta—A Potential Biotherapeutic Agent for Obesity and Associated Metabolic Diseases. Foods, 12. · DOI
  73. Pető, Á., Kósa, D., Szilvássy, Z., Fehér, P., Ujhelyi, Z., Kovács, G., Német, I., Pócsi, I., and Bácskay, I. (2023). Scientific and Pharmaceutical Aspects of Christensenella Minuta, a Promising Next-Generation Probiotic. Fermentation, 9. · DOI
  74. Xu, C., Jiang, H., Feng, L.-J., Jiang, M.-Z., Wang, Y.-L., and Liu, S.-J. (2024). Christensenella Minuta Interacts with Multiple Gut Bacteria. Front. Microbiol., 15. · DOI
  75. Mazier, W., Le Corf, K., Martinez, C., Tudela, H., Kissi, D., Kropp, C., Coubard, C., Soto, M., Elustondo, F., and Rawadi, G. (2021). A New Strain of Christensenella Minuta as a Potential Biotherapy for Obesity and Associated Metabolic Diseases. Cells, 10. · DOI
  76. Liu, 2024, Gut Commensal Christensenella Minuta Modulates Host Metabolism via Acylated Secondary Bile Acids, Nat. Microbiol., 9, 434, 10.1038/s41564-023-01570-0 · DOI
  77. Kropp, C., Le Corf, K., Relizani, K., Tambosco, K., Martinez, C., Chain, F., Rawadi, G., Langella, P., Claus, S.P., and Mar-tin, R. (2021). The Keystone Commensal Bacterium Christensenella Minuta DSM 22607 Displays Anti-Inflammatory Properties Both in Vitro and in Vivo. Sci. Rep., 11. · DOI
  78. Pan, T., Zheng, S., Zheng, W., Shi, C., Ning, K., Zhang, Q., Xie, Y., Xiang, H., and Xie, Q. (2022). Christensenella Regulated by Huang-Qi-Ling-Hua-San Is a Key Factor by Which to Improve Type 2 Diabetes. Front. Microbiol., 13. · DOI
  79. Sun, 2024, Christensenella Strain Resources, Genomic/Metabolomic Profiling, and Association with Host at Species Lev-el, Gut Microbes, 16, 2347725, 10.1080/19490976.2024.2347725 · DOI
  80. Relizani, K., Le Corf, K., Kropp, C., Martin-Rosique, R., Kissi, D., Déjean, G., Bruno, L., Martinez, C., Rawadi, G., and Elustondo, F. (2022). Selection of a Novel Strain of Christensenella Minuta as a Future Biotherapy for Crohn’s Disease. Sci. Rep., 12. · DOI
  81. Suzuki, 2023, The Keystone Gut Species Christensenella Minuta Boosts Gut Microbial Biomass and Voluntary Physical Activity in Mice, mBio, 15, e02836-23
  82. Kumari, 2021, Fostering next-generation probiotics in human gut by targeted dietary modulation: An emerging perspective, Food Res. Int., 150, 110716, 10.1016/j.foodres.2021.110716 · DOI · Paper page
  83. Aeron, G., and Morya, S. (2017). Immobilization and Microencapsulationr. J. Adv. Res. Biotechnol., 2. · DOI
  84. Kowalska, E., Ziarno, M., Ekielski, A., and Żelaziński, T. (2022). Materials Used for the Microencapsulation of Probiotic Bacteria in the Food Industry. Molecules, 27. · DOI
  85. Chen, 2012, Development of a Novel Probiotic Delivery System Based on Microencapsulation with Protectants, Appl. Microbiol. Biotechnol., 93, 1447, 10.1007/s00253-011-3609-4 · DOI
  86. Panjanapongchai, S., Chavapradit, C., and Anal, A.K. (2022). Microencapsulation of Probiotics and Its Potential Industrial Ap-plications. Probiotics, Prebiotics and Synbiotics, John Wiley & Sons, Ltd. · DOI
  87. Chen, 2022, A Narrative Review on Microencapsulation of Obligate Anaerobe Probiotics Bifidobacterium, Akkermansia Muciniphila, and Faecalibacterium Prausnitzii, Food Rev. Int., 38, 373, 10.1080/87559129.2020.1871008 · DOI
  88. Yao, 2020, Progress in Microencapsulation of Probiotics: A Review, Compr. Rev. Food Sci. Food Saf., 19, 857, 10.1111/1541-4337.12532 · DOI · Paper page
  89. Druart, 2021, Toxicological Safety Evalua-tion of Pasteurized Akkermansia Muciniphila, J. Appl. Toxicol., 41, 276, 10.1002/jat.4044 · DOI · Paper page
  90. Khan, 2023, Synergy and Oxygen Adaptation for Development of Next-Generation Probiotics, Nature, 620, 381, 10.1038/s41586-023-06378-w · DOI · Paper page
  91. Noyola, 2006, Treatment of Biogas Produced in Anaerobic Reactors for Domestic Wastewater: Odor Control and Energy/Resource Recovery, Rev. Environ. Sci. Biotechnol., 5, 93, 10.1007/s11157-005-2754-6 · DOI · Paper page
  92. Hwang, O.H., Cho, S.B., Han, D.W., Lee, S.R., Kwag, J.H., and Park, S.K. (2016). Effect of Storage Period on the Changes of Odorous Compound Concentrations and Bacterial Ecology for Identifying the Cause of Odor Production from Pig Slurry. PLoS ONE, 11. · DOI
  93. Mazier, 2021, Safety evaluation of Christensenella minuta as a novel microbiome-based biotherapy to treat obesity, Obesity, 29, 158

Cited by

See all 30

Metadata

Authors
Lalowski, P., & Zielińska, D.
Venue
Fermentation
Publisher
MDPI AG
Published
2024-08-23
Volume
10
Issue
9
Pages
444
ISSN
2311-5637 (ISSN-L)
OpenAlex
W4401805236
Cited by
30
References
18
FWCI
5.84
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.